galactosidase alpha
| UniProt | Protein Name |
|---|---|
| A0A3B3IUC4 |
|
| Q53Y83 |
|
| A0A6Q8PHD1 |
|
| P06280 |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| carbohydrate metabolic process |
|
|
| oligosaccharide metabolic process |
|
|
| oligosaccharide metabolic process |
|
|
| glycoside catabolic process |
|
|
| glycolipid catabolic process |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| extracellular region |
|
|
| cytoplasm |
|
| GO Term | Evidence Code | PMID |
|---|---|---|
| catalytic activity |
|
|
| hydrolase activity, hydrolyzing O-glycosyl compounds |
|
|
| alpha-galactosidase activity |
|
|
| alpha-galactosidase activity |
|
|
| alpha-galactosidase activity |
|
| Gene Ontology |
|---|
| alpha-galactosidase activity |
| galactosidase activity |
| hydrolase activity, acting on glycosyl bonds |
| hydrolase activity |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:14499 | Fabry disease |
| HPO ID | HPO Term |
|---|---|
| HP:0000083 | Renal insufficiency |
| HP:0000091 | Abnormal renal tubule morphology |
| HP:0000093 | Proteinuria |
| HP:0000100 | Nephrotic syndrome |
| HP:0000112 | Nephropathy |
| HP:0000179 | Thick lower lip vermilion |
| HP:0000280 | Coarse facial features |
| HP:0000365 | Hearing impairment |
| HP:0000407 | Sensorineural hearing impairment |
| HP:0000518 | Cataract |
| Disease ID | Disease Name |
|---|---|
| OMIM:301500 |
|
| ORPHA:324 |
|
| Species | Gene ID | Alliance of Genome Resources |
|---|---|---|
| 11605 | MGI:1347344 | |
| 179660 | WB:WBGene00011095 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026